Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
24 04 2022
Historique:
received: 22 03 2022
revised: 20 04 2022
accepted: 21 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Increasing numbers of individuals suffer from post-acute COVID-19 syndrome (PACS), which manifests with persistent symptoms, the most prevalent being dyspnea, fatigue, and musculoskeletal, cognitive, and/or mental health impairments. This systematic review investigated the effectiveness of rehabilitation interventions for individuals with PACS. We searched the MEDLINE, Embase, Cochrane Register of Controlled Trials, CINHAL, Scopus, Prospero, and PEDro databases and the International Clinical Trials Registry Platform for randomized controlled trials (RCTs) up to November 2021. We screened 516 citations for eligibility, i.e., trials that included individuals with PACS exposed to exercise-based rehabilitation interventions. Five RCTs were included, accounting for 512 participants (aged 49.2-69.4 years, 65% males). Based on the revised Cochrane risk-of-bias tool (RoB 2.0), two RCTs had "low risk of bias", and three were in the "some concerns" category. Three RCTs compared experimental rehabilitation interventions with no or minimal rehabilitation, while two compared two active rehabilitation interventions. Rehabilitation seemed to improve dyspnea, anxiety, and kinesiophobia. Results on pulmonary function were inconsistent, while improvements were detected in muscle strength, walking capacity, sit-to-stand performance, and quality of life. Pending further studies based on qualitatively sound designs, these first findings seem to advocate for rehabilitation interventions to lessen disability due to PACS.

Identifiants

pubmed: 35564579
pii: ijerph19095185
doi: 10.3390/ijerph19095185
pmc: PMC9104923
pii:
doi:

Types de publication

Journal Article Review Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Respir Med. 2021 Nov;9(11):1328-1341
pubmed: 34678213
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Scand J Med Sci Sports. 2014 Apr;24(2):259-72
pubmed: 23362828
Enferm Clin (Engl Ed). 2018 Jan - Feb;28(1):5-12
pubmed: 29287828
Med (N Y). 2021 May 14;2(5):501-504
pubmed: 33786465
Int J Environ Res Public Health. 2021 Apr 20;18(8):
pubmed: 33923972
Respir Med. 2012 Dec;106(12):1671-9
pubmed: 23063203
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Respir Med. 2020 Apr - May;165:105930
pubmed: 32174451
Phys Ther. 2021 Nov 1;101(11):
pubmed: 34160029
Respir Med. 2022 Mar 2;195:106782
pubmed: 35272262
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Lancet. 2020 Sep 5;396(10252):e24
pubmed: 32861312
Soc Sci Med. 2021 Jan;268:113426
pubmed: 33199035
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
Eur Respir J. 2020 Aug 13;:
pubmed: 32817258
BMC Geriatr. 2021 Mar 22;21(1):199
pubmed: 33752614
J Infect. 2021 Apr;82(4):e31-e33
pubmed: 33373650
JAMA Netw Open. 2021 May 3;4(5):e2111417
pubmed: 34037731
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
PM R. 2022 Jan;14(1):96-111
pubmed: 34902226
Br J Sports Med. 2020 Aug;54(16):949-959
pubmed: 32475821
Eur J Phys Rehabil Med. 2021 Aug;57(4):663-667
pubmed: 34128607
PM R. 2022 Jan;14(1):77-95
pubmed: 34902224
Clin Rehabil. 2022 Jan;36(1):59-68
pubmed: 34344230
Thorax. 2022 Jul;77(7):697-706
pubmed: 34312316
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
PM R. 2021 Sep;13(9):1027-1043
pubmed: 34346558

Auteurs

Stefania Fugazzaro (S)

Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento n.80, 42123 Reggio Emilia, Italy.

Angela Contri (A)

Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento n.80, 42123 Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio, Via del Pozzo n.74, 41100 Modena, Italy.

Otmen Esseroukh (O)

Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento n.80, 42123 Reggio Emilia, Italy.

Shaniko Kaleci (S)

Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Stefania Croci (S)

Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Marco Massari (M)

Infectious Diseases Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Nicola Cosimo Facciolongo (NC)

Pulmonology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Giulia Besutti (G)

Radiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123 Reggio Emilia, Italy.

Mauro Iori (M)

Medical Physics Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Carlo Salvarani (C)

Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Stefania Costi (S)

Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento n.80, 42123 Reggio Emilia, Italy.
Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH